These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30227084)

  • 1. The Management of Melasma on Skin Types V and VI Using Light Emitting Diode Treatment.
    Mpofana N; Abrahamse H
    Photomed Laser Surg; 2018 Oct; 36(10):522-529. PubMed ID: 30227084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Safety and Efficacy of Treatment With a 1,927-nm Diode Laser With and Without Topical Hydroquinone for Facial Hyperpigmentation and Melasma in Darker Skin Types.
    Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Fabi SG
    Dermatol Surg; 2018 Oct; 44(10):1304-1310. PubMed ID: 29659405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of intense pulsed light in treatment of melasma in Chinese patients.
    Li YH; Chen JZ; Wei HC; Wu Y; Liu M; Xu YY; Dong GH; Chen HD
    Dermatol Surg; 2008 May; 34(5):693-700; discussion 700-1. PubMed ID: 18318729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Q-switched alexandrite laser-assisted treatment of melasma: 2-year follow-up monitoring.
    Rusciani A; Motta A; Rusciani L; Alfano C
    J Drugs Dermatol; 2005; 4(6):770-4. PubMed ID: 16302566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports.
    Polnikorn N
    J Cosmet Laser Ther; 2008 Sep; 10(3):167-73. PubMed ID: 18788035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
    Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
    J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
    Rendon MI; Barkovic S
    J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of melasma with fractional photothermolysis: a pilot study.
    Rokhsar CK; Fitzpatrick RE
    Dermatol Surg; 2005 Dec; 31(12):1645-50. PubMed ID: 16336881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers.
    Kauvar AN
    Lasers Surg Med; 2012 Feb; 44(2):117-24. PubMed ID: 22334295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light-emitting diode 585nm photomodulation inhibiting melanin synthesis and inducing autophagy in human melanocytes.
    Chen L; Xu Z; Jiang M; Zhang C; Wang X; Xiang L
    J Dermatol Sci; 2018 Jan; 89(1):11-18. PubMed ID: 29065997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels.
    Sharquie KE; Al-Tikreety MM; Al-Mashhadani SA
    Dermatol Surg; 2006 Dec; 32(12):1429-36. PubMed ID: 17199649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
    Rivas S; Pandya AG
    Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the treatment of melasma: a review of the recent literature.
    Ball Arefiev KL; Hantash BM
    Dermatol Surg; 2012 Jul; 38(7 Pt 1):971-84. PubMed ID: 22583339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is non-ablative 1550-nm fractional photothermolysis an effective modality to treat melasma? Results from a prospective controlled single-blinded trial in 51 patients.
    Karsai S; Fischer T; Pohl L; Schmitt L; Buhck H; Jünger M; Raulin C
    J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):470-6. PubMed ID: 21569111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of melasma: a review of clinical trials.
    Gupta AK; Gover MD; Nouri K; Taylor S
    J Am Acad Dermatol; 2006 Dec; 55(6):1048-65. PubMed ID: 17097400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of blue light on skin pigmentation in patients with melasma.
    Li L; Jiang X; Tu Y; Yang Y; Zhang X; Gu H; He L
    Skin Res Technol; 2023 Jul; 29(7):e13401. PubMed ID: 37522494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Split-face study of melasma patients treated with non-ablative fractionated photothermolysis (1540 nm).
    Barysch MJ; Rümmelein B; Kolm I; Karpova MB; Schönewolf N; Bogdan Allemann I; Dummer R
    J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):423-30. PubMed ID: 21521377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melasma treated with intense pulsed light.
    Zoccali G; Piccolo D; Allegra P; Giuliani M
    Aesthetic Plast Surg; 2010 Aug; 34(4):486-93. PubMed ID: 20225000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
    Geddes ER; Stout AB; Friedman PM
    Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Evaluation of Efficacy and Tolerability of Glycolic Acid, Salicylic Mandelic Acid, and Phytic Acid Combination Peels in Melasma.
    Sarkar R; Garg V; Bansal S; Sethi S; Gupta C
    Dermatol Surg; 2016 Mar; 42(3):384-91. PubMed ID: 26859648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.